Prescribing differences in family practice for diabetic patients in Germany according to statutory or private health insurance: the case of DPP-4-inhibitors and GLP-1-agonists

BACKGROUND: The objective of this study was to analyze prescription decisions for family practice (FP) patients with Diabetes mellitus type 2 (DM2) using the case of the incretin mimetics Dipeptidyl peptidase-4 (DDP-4) inhibitors and Glucagon-like peptide-1 (GLP-1) agonists dependent on patients’ he...

Descripción completa

Detalles Bibliográficos
Autores principales: Laux, Gunter, Berger, Sarah, Szecsenyi, Joachim, Kaufmann-Kolle, Petra, Leutgeb, Rüdiger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070366/
https://www.ncbi.nlm.nih.gov/pubmed/27760528
http://dx.doi.org/10.1186/s12875-016-0543-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070366/
https://www.ncbi.nlm.nih.gov/pubmed/27760528
http://dx.doi.org/10.1186/s12875-016-0543-7

Ejemplares similares